Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript

Page 2 of 2

And as you know, there was a second or an additional revised offer publicly communicated yesterday. And as I expressed a minute ago, this is, again, an offer that the Board will carefully evaluate with our financial and legal advisers, and that is all we can say for now.

Unidentified Analyst: Understood. And congrats again on all the good work.

Mihael Polymeropoulos: Thank you very much, AJ.

Operator: That concludes our Q&A session. I will now turn the conference back over to Vanda’s management for closing remarks.

Mihael Polymeropoulos: Thank you so much everyone for joining us on this first quarter call. And we look forward to talking to you in future periods.

Operator: Ladies and gentlemen, that concludes today’s call. Thank you all for joining. You may now disconnect.

Follow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Page 2 of 2